Abstract:Peripheral T-Cell lymphoma (PTCL) comprises a heterogenous group of uncommon lymphomas derived from mature, post-thymic or “peripheral” T- and natural killer cells. The World Health Organization (WHO) emphasizes a multiparameter approach in the diagnosis and subclassification of these neoplasms, integrating clinical, morphologic, immunophenotypic, and genetic features into the final diagnosis. Clinical presentation is particularly important due to histologic, immunophenotypic and genetic variations within established subtypes, and no convenient immunophenotypic marker of monoclonality exists. In recent years, widespread use of gene expression profiling and next-generation sequencing (NGS) techniques have contributed to an improved understanding of the pathobiology in PTCLs, and these have been incorporated into the 2016 revised WHO classification of mature T- and NK-cell neoplasms which now encompasses nearly 30 distinct entities. This review discusses the genetic landscape of PTCL and its role in subclassification, prognosis, and potential targeted therapy. In addition to discussing T-Cell lymphoma subtypes with relatively well-defined or relevant genetic aberrancies, special attention is given to genetic advances in T-Cell lymphomas of T follicular helper cell (TFH) origin, highlighting genetic overlaps between angioimmunoblastic T-Cell lymphoma (AITL), follicular T-Cell lymphoma, and nodal peripheral T-Cell lymphoma with a TFH phenotype. Furthermore, genetic drivers will be discussed for ALK-negative anaplastic large cell lymphomas and their role in differentiating these from CD30+ peripheral T-Cell lymphoma, not otherwise specified (NOS) and primary cutaneous anaplastic large cell lymphoma. Lastly, a closer look is given to genetic pathways in peripheral T-Cell lymphoma, NOS, which may guide in teasing out more specific entities in a group of T-Cell lymphomas that represents the most common subcategory and is sometimes referred to as a “wastebasket” category.

Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification

Epidemiology and Pathology of T- and NK-Cell Lymphomas

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification

Updates in the Treatment of Peripheral T-Cell Lymphomas

Research Progress in Treatment of Peripheral T-cell Lymphoma

[Current standard in diagnostic and therapy of peripheral T-cell lymphoma]

Lymphoma classification update: B-cell non-Hodgkin lymphomas

Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues

New insights into the biology of T-cell lymphomas

Review of the 2016 WHO Classification of Lymphoid Neoplasms

Classification of B-Cell Lymphomas and Immunodeficiency-Related Lymphoproliferations: What’s New?

Genetic Landscape of Peripheral T-Cell Lymphoma

The World Health Organization Classification of Lymphoid Neoplasms

The fifth edition of the WHO-Classification - what is new for cutaneous lymphomas?

New advances in lymphoma pathology

SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas

Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management

Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group

Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs)

Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasms – a practical guide to WHO HAEM5

The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update